Dr Tony Elliott is a leading Consultant Oncologist with a special interest in genito-urinary cancers. He provides an unparalleled service with HCA Healthcare, helping those at a time when they need it most. He offers a holistic approach to treatment, using chemotherapy, hormone therapy, external beam radiotherapy, and brachytherapy.

Dr Elliott graduated from Edinburgh University with a medical degree in 1993 and completed his specialist oncology training. He was awarded his specialised accreditation from the Royal College of Radiologists in 2001. Following this, he completed a Clinical Research Fellowship to investigate the mechanisms of cancer resistance to chemotherapy and radiotherapy, and was awarded a PhD for his outstanding work. Throughout his career, he has published numerous papers and is a prominent physician in his field. He is a member of the National Cancer Research Institute's Hormone Resistant Prostate Cancer Group, Bladder Cancer Chemotherapy Group, and Penile Cancer Group.

Dr Elliott's areas of expertise include radiotherapy, chemotherapy, and hormone therapy. He specialises in treating genito-urinary cancers, including prostate cancer, penile cancer, bladder cancer, and urothelial cancer. Since his appointment, he has been dedicated to providing comprehensive and compassionate care to his patients.

In addition to his clinical roles, Dr Elliott is actively involved in research and education, contributing to the advancement of oncology through his work and publications. His commitment to understanding and overcoming cancer resistance has made significant impacts in the field, benefiting both his patients and the wider medical community.